IBRX SHAREHOLDER ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - IBRXPRNewsWire • 07/23/23
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 07/21/23
ImmunityBio Announces Execution of $40 Million Equity Financing with Institutional InvestorsBusiness Wire • 07/21/23
INVESTOR DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $500,000 to Contact the FirmAccesswire • 07/19/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $500,000 to Contact the FirmAccesswire • 07/17/23
INVESTOR ACTION ALERT: Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against ImmunityBio, Inc. (NASDAQ: IBRX); Lead Plaintiff Deadline is August 29, 2023Business Wire • 07/12/23
ImmunityBio, Inc. (IBRX) Stock News: Investors with Large Losses Should Contact Robbins LLP Regarding ImmunityBio, Inc. Class ActionBusiness Wire • 07/11/23
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ImmunityBio, Inc. (IBRX)Business Wire • 07/11/23
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $500,000 to Contact the FirmAccesswire • 07/11/23
Phase 1 Study Indicates Allogeneic Cytokine-Induced Memory-Like Natural Killer Cells Plus N-803 May Induce Tumor Regression in Advanced Head-and-Neck Cancer PatientsBusiness Wire • 07/10/23
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 07/08/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of ImmunityBio, Inc. (IBRX) InvestorsBusiness Wire • 07/07/23
Calling All ImmunityBio, Inc. (IBRX) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today!Business Wire • 07/07/23
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $250,000 to Contact the FirmAccesswire • 07/07/23
SHAREHOLDER ACTION REMINDER: Scott+Scott Attorneys at Law LLP Reminds Investors That a Securities Class Action Has Been Filed Against ImmunityBio, Inc. (NASDAQ: IBRX); Lead Plaintiff Deadline is August 29, 2023Business Wire • 07/06/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of ImmunityBio, Inc. (IBRX) on Behalf of InvestorsBusiness Wire • 07/05/23
The Law Offices of Frank R. Cruz Announces Investigation of ImmunityBio, Inc. (IBRX) on Behalf of InvestorsBusiness Wire • 07/05/23
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ImmunityBio, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - IBRXPRNewsWire • 07/04/23
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 07/04/23
EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages ImmunityBio, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – IBRXBusiness Wire • 07/03/23
INVESTOR DEADLINE ACTION ALERT: The Schall Law Firm Encourages Investors in ImmunityBio, Inc. with Losses of $100,000 to Contact the FirmAccesswire • 07/03/23
IMMUNITYBIO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against ImmunityBio, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 07/02/23
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against ImmunityBio, Inc. (IBRX)Business Wire • 07/01/23
